Connection

Taishi Yonezawa to Leukemia, Myeloid, Acute

This is a "connection" page, showing publications Taishi Yonezawa has written about Leukemia, Myeloid, Acute.
Connection Strength

0.248
  1. IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia. EMBO Mol Med. 2023 01 11; 15(1):e15631.
    View in: PubMed
    Score: 0.139
  2. Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms. Sci Rep. 2019 06 03; 9(1):8171.
    View in: PubMed
    Score: 0.109
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.